Monday, June 2, 2025
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

Endogenex™ Appoints Krissy Wright as Chief Financial Officer

by
January 14, 2025
in PR Newswire
0
Endogenex™ Appoints Krissy Wright as Chief Financial Officer
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Bringing finance, operational, and corporate development expertise to an experienced leadership team.

MINNEAPOLIS, Jan. 15, 2025 /PRNewswire/ — Endogenex, Inc., a clinical-stage medical device company, is proud to announce the addition of Krissy Wright as Chief Financial Officer (CFO). In this role, Wright will lead Endogenex’s financial strategy, corporate development initiatives, and operational planning to support the advancement of the company’s clinical initiatives.

Related posts

CIMB Singapore and Wing Bank Forge Strategic Partnership to Boost Cross-Border Financial Services Between Singapore and Cambodia

CIMB Singapore and Wing Bank Forge Strategic Partnership to Boost Cross-Border Financial Services Between Singapore and Cambodia

June 2, 2025
CIMB Singapore and Wing Bank Forge Strategic Partnership to Boost Cross-Border Financial Services Between Singapore and Cambodia

CIMB Singapore and Wing Bank Forge Strategic Partnership to Boost Cross-Border Financial Services Between Singapore and Cambodia

June 2, 2025

“We are thrilled to welcome Krissy to the Endogenex leadership team,” said Stacey Pugh, CEO of Endogenex. “Her extensive experience in financial strategy, corporate development, and leadership in the MedTech industry will be instrumental as we work to achieve our clinical milestones and deliver transformative solutions to type 2 diabetes management.”

Krissy brings experience from Cleerly, an AI-driven heart diagnostics company, where she served as CFO, and from Medtronic, where she held leadership roles including Vice President and General Manager of Brain Modulation and Vice President and Chief Financial Officer for the Neuromodulation Operating Unit. Earlier in her career, she spent 11 years at PricewaterhouseCoopers, specializing in Audit, Assurance, and Transaction Services.

“I am thrilled to be joining Endogenex at such a pivotal moment in its journey,” said Wright. “The company’s novel approach to addressing type 2 diabetes can potentially transform the lives of millions worldwide. I look forward to leveraging my financial expertise to support the team in advancing this groundbreaking therapy and achieving our mission of delivering meaningful, scalable healthcare solutions.”

The ReCET Procedure:
ReCET is a novel, endoscopic, outpatient procedure that targets the underlying cellular abnormalities in the duodenum that contribute to the development and progression of type 2 diabetes.

By applying highly controlled, non-thermal pulsed electric fields, the ReCET Procedure is designed to initiate the body’s natural regenerative process to restore proper cellular signaling from the duodenum and improve glycemic control.

The ReCET Procedure is currently being evaluated in global pre-commercialization trials assessing its safety and efficacy in adults with type 2 diabetes who are inadequately controlled despite the use of insulin and non-insulin medications. The ReCET Procedure has received Breakthrough Device Designation from the FDA for the treatment of type 2 diabetes in adult patients inadequately controlled by glucose-lowering medications.

About Endogenex:
Endogenex is a privately held, clinical-stage company headquartered in Minneapolis, MN. Endogenex was founded in partnership with Mayo Clinic to develop therapies to improve outcomes for people living with type 2 diabetes. Endogenex focuses on the principle that effective treatment for type 2 diabetes can extend beyond pharmaceutical options, correct metabolic function, and help people regain control of their blood glucose levels.

For more information, please visit our website at www.endogenex.com.

Media Inquiries:
Krissy Wright
[email protected]
+1 651 329 5413

Logo – https://mma.prnewswire.com/media/2446687/2312_1673_DY23_ENDOGENEX_HORIZONTAL_LOGO_POSITIVE_CMYK_Logo_Logo.jpg

View original content:https://www.prnewswire.com/apac/news-releases/endogenex-appoints-krissy-wright-as-chief-financial-officer-302348148.html

SOURCE Endogenex

​ 

Previous Post

Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters

Next Post

Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales

Next Post
Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales

Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • CIMB Singapore and Wing Bank Forge Strategic Partnership to Boost Cross-Border Financial Services Between Singapore and Cambodia
  • CIMB Singapore and Wing Bank Forge Strategic Partnership to Boost Cross-Border Financial Services Between Singapore and Cambodia
  • Crush Colossal Kaiju with a Game-Changing Blow: KAIJU NO. 8 THE GAME Unveils Details for Original Story!

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved